Objective-Experimental studies suggest that maternal hypercholesterolemia may be relevant for the early onset of cardiovascular disease in offspring. We investigated the effect of perinatal hypercholesterolemia on the atherosclerosis development in the offspring of apolipoprotein E-deficient mice and the underlying mechanism. Approach and Results-Atherosclerosis and related parameters were studied in adult male or female apolipoprotein E-deficient mice offspring from either normocholesterolemic or hypercholesterolemic mothers and normocholesterolemic fathers. Female born to hypercholesterolemic mothers had more aortic root lesions than female born to normocholesterolemic mothers. Lesions in whole aorta did not differ between groups. Higher trimethylamine-N-oxide levels and Fmo3 hepatic gene expression were higher in female born to hypercholesterolemic mothers offspring compared with female born to normocholesterolemic mothers and male. Trimethylamine-N-oxide levels were correlated with the size of atherosclerotic root lesions. Levels of hepatic cholesterol and gallbladder bile acid were greater in male born to hypercholesterolemic mothers compared with male born to normocholesterolemic mothers. At 18 weeks of age, female born to hypercholesterolemic mothers showed lower hepatic Scarb1 and Cyp7a1 but higher Nr1h4 gene expression compared with female born to normocholesterolemic mothers. Male born to hypercholesterolemic mothers showed an increase in Scarb1 and Ldlr gene expression compared with male born to normocholesterolemic mothers. At 25 weeks of age, female born to hypercholesterolemic mothers had lower Cyp7a1 gene expression compared with female born to normocholesterolemic mothers. DNA methylation of Fmo3, Scarb1, and Ldlr promoter regions was slightly modified and may explain the mRNA expression modulation. Conclusions-Our findings suggest that maternal hypercholesterolemia may exacerbate the development of atherosclerosis in female offspring by affecting metabolism of trimethylamine-N-oxide and bile acids. These data could be explained by epigenetic alterations. Visual Overview-An online visual overview is available for this article. 
A therosclerosis is one of the most important causes of death and disability throughout the world. Its progression depends on several factors, such as dyslipidemia, hypertension, and diabetes mellitus. However, the presence of these risk factors does not fully explain the development and progression of atherosclerosis. Some subjects with increased levels of low-density lipoprotein (LDL) cholesterol do not develop atherosclerosis or develop only mild symptoms. 1 Epidemiological observational studies on cohorts have shown an increased severity of cardiovascular diseases in offspring when the disease was transmitted through the mothers. [2] [3] [4] Indeed, fetal cholesterol has been correlated with maternal levels during early pregnancy, 5 and increase fatty streaks have been observed in the aorta of 6-month-old fetus born to hypercholesterolemic mothers. 6 
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The Developmental Origins of Health and Disease concept 7 states that the occurrence of numerous disease, including the cardiovascular diseases, in adults is linked to the environmental conditions of early life. In animal studies, in utero programming by maternal hypercholesterolemia is better characterized compared with any other risk factor. 8 Several potential mechanisms have already been described to possibly enhance atherosclerosis development in offspring born to hypercholesterolemic mothers. Perinatal high-fat diet or genetically hypercholesterolemia lead to impaired vascular relaxation, 9 endothelial dysfunction, 10 altered arterial gene expression, 11 and cholesterol synthesis 12 while manipulating the level of plasma cholesterol of pregnant animals affects the metabolic and cardiovascular phenotype of their offspring. [13] [14] [15] Exposure to hypercholesterolemia has been also shown to induce epigenetics alteration, 11 which can explain such intrauterine programming for the subsequent development of cardiovascular disease during adulthood.
Homozygous apolipoprotein E-deficient (ApoE −/− ) mice are considered as a good model of the spontaneous and early development of atherosclerosis. 16 In the present work, we aimed to examine whether the perinatal (gestation and lactation) cholesterolemia accelerates the development of atherosclerosis in ApoE −/− offspring under chow diet at 18 weeks (early lesions) and 25 weeks (intermediate to advanced lesions) and sought to identify the underlying mechanisms. We specially focused on trimethylamine-N-oxide (TMAO), lipids, and bile acids (BA) metabolism, reported to be altered in cardiovascular disease, 17 and we examined the epigenetic modifications of the promoter of key genes involved in these metabolisms. For this, we studied ApoE −/− offspring born to parents that have never yet been studied, that is normocholesterolemic ApoE +/− male crossed with normocholesterolemic ApoE +/− or hypercholesterolemic ApoE −/− female.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
Compared with control mothers (N), ApoE −/− mothers (H) displayed gestational hypercholesterolemia and atherogenic lipid profile ( Figure II in the online-only Data Supplement). At the beginning of gestation, we showed high very-low-density lipoprotein and LDL cholesterol levels in ApoE −/− female. Although plasma total cholesterol decreased during pregnancy in both groups, hypercholesterolemic mothers had significant higher levels than normocholesterolemic mothers (first day of gestation: 401.3±61. 4 Figure 1A and 1B). En face analyses of thoracic and abdominal aortic areas in all groups showed the lesions covered from 7% to 10% of the whole aorta at 18 weeks old and from 10% to 13% at 25 weeks old. The area of lesions in thoracic and abdominal aorta at 18 and 25 weeks was not significantly different between groups ( Figure 1C ). At 18 weeks, aortic arch triglycerides and cholesterol content were higher in F-H (29.0±6.8 and 8.0±2.9 mg/g, respectively) compared with F-N mice (11.4±9.8 and 2.3±1.4 mg/g, respectively; P<0.05; Figure 1D and 1E). Total aortic arch cholesterol rose from 18 to 25 weeks in M-H (from 6.2±6.0 to 16.8±10.5 mg/g) and F-H mice (from 8.0±2.9 to 19.8.8±12.4 mg/g; Figure 1D and 1E).
Perinatal hypercholesterolemia induced changes in fasting TMAO levels in offspring. At 18 weeks, TMAO concentrations were higher in F-H (21.8±7.7 µmol/L) compared with F-N mice (8.3±3.3 µmol/L; P<0.05). TMAO levels in female were ≈3× to 6× higher than they were in male at both 18 and 25 weeks (Figure 2A ). TMAO levels were lower at 25 weeks compared with 18 weeks in M-H and F-H mice (1.5±1.1 versus 4.3±0.8 µmol/L; P<0.05 and 8.9±3.1 versus 21.8±7.7 µmol/L; P<0.05, respectively) and did not differ anymore between F-H and F-N or M-H and M-N at 25 weeks. Choline, carnitine, and betaine concentrations, 3 precursors of TMAO synthesis, were not different between groups at 18 weeks ( Figure 2B-2D) . However, carnitine levels were significantly lower in F-H than F-N at 25 weeks ( Figure 2C ).
Perinatal hypercholesterolemia modulated the lipid profile in ApoE −/− offspring. Although total plasma cholesterol levels were similar at 10, 18, and 25 weeks ( Figure 2E ), triglyceridemia at 18 weeks were significantly higher in F-H (86.3±10.7 mg/dL) compared with F-N mice (59.2±4.8 mg/ dL; Figure 2F ). We did not observe any difference in triglyceridemia between male. Maternal hypercholesterolemia led to a modification of hepatic cholesterol and triglycerides levels, as well as gallbladder BA concentration in the ApoE −/− offspring. Hepatic triglycerides content was higher in M-H compared with M-N at 18 (P<0.05) and 25 weeks (P<0.05; Figure 3A) , and liver weight was higher in M-H compared with M-N at 18 weeks old (P<0.05; Table) . Hepatic cholesterol content did not differ between groups at 18 weeks old. But at 25 week old, M-H mice showed higher hepatic cholesterol content (4.7±0.3 mg/g) than did M-N (2.3±1.1 mg/g; P<0.05) or F-H mice (3.2±0.9 mg/g; P<0.01; Figure 3B ). We did not observe mice from the indicated normocholesterolemic (shaded) mothers vs hypercholesterolemic mothers (hatched) and sexes (n=5-7; B). Quantification of the Oil-Red-O/hematoxylin staining of en face preparations representing percent of total area of the thoracic and abdominal aorta covered by plaque (n=5-7; C). Aortic cholesterol and triglyceride were quantified in aortic arch (n=5-7). D and E, Mann-Whitney, nonparametric t test was used for comparison between 2 groups. Symbols represented results significantly different: * was used for comparison between offspring born to hypercholesterolemic mothers vs normocholesterolemic mothers; † was used for comparison between male and female. Data were presented as median and quartile±SD. Statistical significance was set at P<0.05. F-H indicates female offspring born to hypercholesterolemic mothers; F-N, female offspring born to normocholesterolemic mothers; M-H, male offspring born to hypercholesterolemic mothers; M-N, male offspring born to normocholesterolemic mothers; TC, cholesterolemia; and TG, triglyceridemia. Figure 4D1 and 4D2). Perinatal hypercholesterolemia modulates the expression of genes involved in the metabolism of TMAO, lipids, and BA in the offspring. We observed increased Fmo3 mRNA expression in livers from F-H mice compared with livers from F-N mice at 18 weeks but not at 25 weeks ( Figure 5A ). Fmo3 levels were undetectable in liver samples from male (data not shown). At 18 weeks, Scarb1 (gene encoding scavenger receptor class B member 1) was downregulated in livers of F-H compared with F-N mice. Hepatic low Ldlr and Scarb1 expressions were both increased in M-H compared with M-N mice ( Figure 5B and 5C). Ldlr expression was higher in male than female at 18 weeks old ( Figure 5B ). Cyp7a1 expression did not differ between female offspring while Nr1h4 (gene encoding farnesoid x receptor [FXR]) mRNA expression was increased in female born to hypercholesterolemic mothers compared with those born to normocholesterolemic mothers at 18 weeks. At 25 weeks old, Cyp7a1 and Nr1h4 gene expressions were decreased in F-H compared with M-H and female compared with male, respectively ( Figure 5D and 5E).
Gene expression and silencing are associated with DNA methylation in promoter regions, and therefore aberrant DNA methylation may underlie cardiovascular pathogenesis. 18, 19 It has been shown that DNA methylation may be affected by S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) levels in cells. 20 Thus, we measured the liver content of SAM, SAH, and SAM to SAH ratio and methylation of promoter regions of overexpressed or underexpressed genes in the present study. We showed that pregnancy hypercholesterolemia is accompanied with change in methylation potential in the liver at 18 and 25 weeks age of offspring ( Figure VA and VB in the online-only Data Supplement). The SAM liver content did not differ between female offspring or male offspring while SAH content was higher in F-H (35.3±10.1 nmol/g of proteins) compared with M-H (16.1±3.1 nmol/g of proteins) at 18 weeks (P<0.01). We observed a tendency to increasing methylation as measured by the SAM:SAH ratio in F-H compared with F-N (P=0.06). The SAM/SAH ratio tented to a decrease in F-N compared with M-N (P=0.09; Figure VC in the online-only Data Supplement). , betaine (C), and carnitine (D) concentrations were measured in offspring born to normocholesterolemic or hypercholesterolemic mothers at 18 and 25 wk. Cholesterolemia (TC; E) and triglyceridemia (TG; F) levels were determined in 10-, 18-, and 25-wk male and female ApoE −/− born to normocholesterolemic (shaded) or hypercholesterolemic mothers (hatched in the figure). Mann-Whitney, nonparametric t test was used for comparison between 2 groups. Symbols represent significant results: * was used for comparison between offspring born to hypercholesterolemic mothers as compared with those born to normocholesterolemic mothers; † was used for comparison between male and female. Data were presented as median and quartile±SD. Statistical significance was set at P<0.05. F-H indicates female offspring born to hypercholesterolemic mothers; F-N, female offspring born to normocholesterolemic mothers; M-H, male offspring born to hypercholesterolemic mothers; and M-N, male offspring born to normocholesterolemic mothers.
A total of 40 CpG sites present in the promoter regions of Fmo3, Scarb1, LdlR, Cyp7a1, and Nr1h4 genes were analyzed by pyrosequencing. Only 3 CpG sites are present in the Fmo3 promoter ( Figure 6A ). The methylation level over this region harbored a great heterogeneity (from 20% to ≈60% from one CpG site to another). Methylation levels were significantly higher for all CpG sites in the male groups compared with the female groups (CpG1: 30% methylation versus 15% methylation, P<0.01; CpG2: 65% methylation versus 60% methylation, P<0.05; and CpG3: 55% methylation versus 25% methylation, P<0.01; Figure 6A ). We did not observe any difference between animals born to hypercholesterolemic mothers compared with normocholesterolemic ones. We analyzed 11 CpG sites (10-14 and 20-25) out of the 34 CpG sites present in the Scarb1 promoter, and the methylation levels varied from 0% to 80% ( Figure 6B ). Only the CpG12 methylation level was slightly increased in M-N compared with M-H and F-H (CpG12 79% methylation versus 70% methylation, P=0.07 and P=0.09, respectively; Figure 6B ). We analyzed the methylation level of 18 CpG sites out of 24 in the promoter region of Ldlr ( Figure 6C) . The average methylation level of CpG 1 to 6 was significantly higher in F-N compared with M-N (+5% in each CpGs; P<0.01), and we observed a significant decrease in CpG7, 8, and 18 between M-H compared with M-N (CpG7 14% methylation versus 10% methylation, P<0.05; GpG8 6% methylation versus 4% methylation, P<0.01; and CpG18 4% methylation versus 2% methylation, P=0.07; Figure 6C ). The methylation levels of 4CpGs out of 8 in the Cyp7a1 promoter region were similar between groups, and we did not observe any difference in the methylation level of 4CpGs out of 7 in the Nr1h4 promoter region (data not show). Figure IV in the online-only Data Supplement. Mann-Whitney, nonparametric t test was used for comparison between 2 groups. Symbols represented results significantly different: * was used for comparison between offspring born to hypercholesterolemic mothers and those born to normocholesterolemic mothers; † was used for comparison between male and female. Data were presented as median and quartile±SD. Statistical significance was set at P<0.05. F-H indicates female offspring born to hypercholesterolemic mothers; F-N, female offspring born to normocholesterolemic mothers; M-H, male offspring born to hypercholesterolemic mothers; and M-N, male offspring born to normocholesterolemic mothers.
Discussion
Recent studies support the Developmental Origins of Health and Disease concept and suggest that the perinatal environment could have a long-lasting impact on metabolism, promoting the development of atherosclerosis in adulthood. 7 Using original parent's pair, the present study confirmed that perinatal hypercholesterolemia accelerated the development of atherosclerosis in ApoE −/− offspring. Female offspring born to hypercholesterolemic mothers exhibited more atherosclerotic plaques as early as 18 weeks than the female offspring born to normocholesterolemic mothers or male offspring born to hypercholesterolemic mothers. These results are related to a change in TMAO and BA metabolism probably linked to a modification of cell methylation potential measured by liver SAM: SAH ratio and DNA methylation of studied genes.
In animal models, in utero programming by maternal hypercholesterolemia is better characterized than programming by any other risk factor, 8 but effects on adult coronary heart disease remain poorly understood. Previous results in various animal models have suggested that gestational hypercholesterolemia may program atherosclerosis in offspring of New Zealand rabbit and ApoE +/− mice and Ldlr −/− mice 13, 21, 22 and provided important information about the mechanisms that link maternal cholesterolemia to development of atherosclerosis in the developing fetus and in adult. This causal role of maternal hypercholesterolemia in atherogenesis is also supported by a decrease in offspring atherosclerotic lesions when mothers received cholesterol-lowering treatment during pregnancy. 13, 15 Furthermore, because hypercholesterolemia is accompanied by increased plasma levels of lipids peroxidation, 23 ,24 a supplementation with vitamin E during pregnancy also markedly reduced fetal lesion sizes. 13, 14 The results of the present study confirmed these observations and showed that ApoE −/− female born to hypercholesterolemic mothers developed at earlier age more severe aortic root neutral lipid-stained lesions than did female born to normocholesterolemic or male. This sex difference was already observed at the same age in ApoE +/− born to ApoE −/− mother and ApoE +/+ father compared with those from ApoE +/+ mothers and ApoE −/− father. 25 Napoli et al 22 did not observe the difference between sex in the FELIC study (Fate of Early Lesions in Children) 6 nor in New Zealand rabbit 13 or Ldlr −/− mice. This divergence could be explained by the difference of the age of offspring (18 and 25 weeks) chosen in the present study to measure the lesions and the studied species. It was reported that female ApoE −/− mice exhibit mature fibrofatty atherosclerotic plaques as early as 16 or 25 weeks of age, 26 and they have significantly larger lesions compared with age-matched male. 26, 27 This difference in lesion size between male and female is also observed in response to treatments at younger ages. 27 In our study, we did not examine the progeny at advanced ages, but it was reported that at the age of 48 weeks, lesions are equal between female and male mice and even larger in male. 26 It would be interesting in the future study to check the effect of perinatal cholesterolemia at advanced ages of offspring. Also an additional experiment in another model of human familial hypercholesterolemia, in particular the Ldlr −/− , is also needed to confirm the observed effect of perinatal cholesterolemia on atherosclerosis development at adult age.
Although maternal hypercholesterolemia plays a major role in the atherogenesis of offspring, the underlying mechanisms are not fully known. This perinatal hypercholesterolemia can act via several mechanisms, such as lipid metabolism, 12 lipid peroxidation, 13 or other factors not yet identified as TMAO and BA metabolism.
TMAO, metabolite generated from other nutrients, including choline, and carnitine after their conversion by gut microbiota to trimethylamine (TMA) were reported to be highly predictive of the progression of atherosclerosis in animals and humans 17, 28, 29 and to enhance platelet hyper-reactivity in animals and humans and thrombosis risk in mice. 30 In the current study, the level of TMAO was increased in offspring born to hypercholesterolemic mothers at 18 weeks while this difference disappears at 25 weeks. TMAO levels were also 5× to 8× higher in female than those observed in male. Noteworthy, at 18 and 25 weeks, TMAO levels were positively correlated with the early root neutral lipid-stained lesions but not with the lesions in the thoracic and abdominal aorta.
The conversion of TMA into TMAO is catalyzed by flavincontaining monooxygenase 3. Female from hypercholesterolemic mothers had a higher TMAO level and Fmo3 expression Mann-Whitney, nonparametric t test was used for comparison between 2 groups. Symbols represent significant results. F-H indicates female offspring born to hypercholesterolemic mothers; F-N, female offspring born to normocholesterolemic mothers; M-H, male offspring born to hypercholesterolemic mothers; and M-N, male offspring born to normocholesterolemic mothers.
*Used for comparison between offspring born to normocholesterolemic vs hypercholesterolemic mothers. †Used for comparison between male and female. Data were presented as median and quartile±SD. Statistical significance was set at P<0.05.
at 18 weeks compared with the female born to normocholesterolemic mothers. This result is in accordance with a significant increase of Fmo3 expression reported by Napoli et al 22 in nonatherosclerotic media and intima of Ldlr −/− offspring mice born to hypercholesterolemic mothers.
DNA methylation level of Fmo3 promoter site could not explain the difference of expression between animals born to hypercholesterolemic compared with normocholesterolemic mothers. Transcriptional regulation of the Fmo3 gene remains poorly understood and controversial. In HepG2 cells, DNA methylation is responsible for silencing Fmo3. 31 However, although Fmo3 gene expression is absent or low during the neonatal period, there is no difference in Fmo3 CpG methylation in fetus as compared with adult humans. 32 Hepatic FXR, but not intestinal FXR, has already shown to regulate hepatic Fmo3 gene expression. 33 In our study, the expression of Nr1h4 mRNA (encoding FXR) was increased in animals born to hypercholesterolemic mothers compared with normocholesterolemic Figure 4 . Correlation between trimethylamine-N-oxide (TMAO), cholesterolemia, triglyceridemia, and atherosclerotic lesional area at 18-and 25-wk-old mice. Correlation analysis was performed to examine the pairwise relationships between aortic root neutral lipid-stained lesion area and plasma TMAO levels (A), aortic lesions in thoracic and abdominal and plasma TMAO levels (B), aortic root neutral lipidstained lesion area and cholesterolemia (C), and triglyceridemia (D) among 18 to 20 offspring at 18 wk (A 1 , B 1 , C 1 , D 1 ) and 25 wk (A 2 , B 2 ,  C 2 , D 2 ). Stepwise linear regression analysis was performed to examine the relative importance of plasma TMAO levels, cholesterolemia, and triglyceridemia in influencing aortic lesion area in root or whole aorta among offspring. mothers (discussed below), especially in female and may partially explain the increased expression of Fmo3.
The low TMAO levels measured in the male could be explained by the undetectable expression of Fmo3. In our study, we observed a hypermethylation of Fmo3 promoter site in male compared with female. We identified several putative transcription factors response elements as glucocorticoid, androgen, and progesterone receptor-binding sites but also sex-determining region Y element response (Data V in the online-only Data Supplement), which could explain our results. In the present study, although female mice exhibited undetectable levels of TMA, ApoE −/− male showed elevated levels of this metabolite (average, 2 µmol/L TMA, data not shown). Previous study shows that silencing of hepatic Fmo3 results in TMA accumulation decreased circulating TMAO levels and atherosclerosis in Ldlr −/− mice. 34 The TMAO levels in offspring could be related to the TMAO level of their mothers. Indeed, previous studies have shown that TMAO levels are a transmissible trait after microbial transplantation 35 and have reported a mechanistic link between gut microbiota and epigenetic changes in offspring. 36 The direct involvement of TMAO in the observed results is discarded because hypercholesterolemic mothers did not show an increase in TMAO compared with normocholesterolemic mothers ( Figure II in the online-only Data Supplement), which is concordant with the lack of difference between offspring female at 25 weeks. However, we cannot totally discard the effect of a possible transfer of microbiota from the mothers to the offspring.
We further assessed other parameters tightly linked to the development of atherosclerosis. Of note, there was no significant difference between total cholesterolemia at 10-, 18-, and C) , and bile acids (D and E) metabolism was quantified by quantitative polymerase chain reaction from 18-to 25-wk apolipoprotein E-deficient offspring born to normocholesterolemic (shaded) or hypercholesterolemic mothers (hatched). The expression of GAPDH was used as a reference value to normalize the studied genes expression. Relative quantitative gene expression was calculated by the 2 −ΔΔCt method with male offspring born to normocholesterolemic mothers (M-N) group as calibrator. Mann-Whitney, nonparametric t test was used for comparison between 2 groups. Symbols represented results significantly different: * was used for comparison between offspring born from hypercholesterolemic mothers vs normocholesterolemic mothers; † was used for comparison between male and female. Data were presented as median and quartile±SD. Statistical significance was set at P<0.05. F-H indicates female offspring born to hypercholesterolemic mothers; F-N, female offspring born to normocholesterolemic mothers; and M-H, male offspring born to hypercholesterolemic mothers.
25-week-old mice in offspring born to hypercholesterolemic mothers and offspring born to normocholesterolemic mothers. This result is in accordance with those obtained in ApoE +/− offspring born to hypercholesterolemic mothers (crossed with normocholesterolemic fathers) compared with normocholesterolemic mothers (crossed with hypercholesterolemic fathers) 25 and in children from hypercholesterolemic mothers. 2 Similarly, there was no correlation between maternal cholesterol levels and fetuses plasma beyond sixth month of fetal age. 5 Cholesterol homeostasis is regulated by the reverse cholesterol transport where liver is the central organ controlling the rate of plasma cholesterol uptake and its elimination via direct secretion into bile or by conversion to BA. We observed higher hepatic cholesterol levels at 25 weeks in male born to hypercholesterolemic mothers as compared with those born to normocholesterolemic mothers. Although Scarb1 mRNA expression decreased in female born to hypercholesterolemic mice, expression of Scarb1 and Ldlr increased in male born to hypercholesterolemic mothers. Supplementation of mothers with methyl donor increase the mRNA expression of Scarb1 in mice offspring 37 and decrease Ldlr in piglet offspring. 38 In this later study, it showed that the promoter of Ldlr was hypermethylated and had more enriched H3K27me3 mark. 38 Hypomethylation of Ldlr gene in its regulatory region also lead to increase mRNA expression in human adipose tissue. 39 In our study, DNA methylation level of Scarb1 promoter site was similar in offspring born to hypercholesterolemic and normocholesterolemic mothers, but we observed many differences in CpGs methylation in Ldlr promoter site. The average methylation level of CpG 1 to 6 was significantly higher in female born to normocholesterolemic mothers compared with male born to normocholesterolemic mothers and lower in CpG7, 8, and 18 in male born to hypercholesterolemic mothers compared with male born to normocholesterolemic mothers. These changes of the measured Scarb1 and Ldlr DNA methylation may explain the observed expression of these 2 genes and support the observed data on cholesterol metabolism. We also determined the profile and content of the gallbladder BA and measured the expression of Cyp7a1 and Nr1h4, 2 genes involved in their metabolism. Interestingly, 18 and 25 weeks male born to hypercholesterolemic mothers had higher levels of unconjugated, tauro-conjugated, and glycoconjugated BA as compared with female. Cyp7a1 mRNA expression was higher in male born to hypercholesterolemic mothers as compared with female. Although there was no difference in BA content or profile between female born to hypercholesterolemic mothers and those born to normocholesterolemic ones, Cyp7a1 gene expression was lower in the first group at 25 week old. Such a difference may not be clinically significant but could be revealed by feeding the female offspring a hypercholesterolemic or high saturated fat diet. Compared with female offspring of normocholesterolemic mothers, female offspring of hypercholesterolemic mothers showed increased Nr1h4 expression at 18 weeks old. BA elimination is the major mechanism for reverse cholesterol transport and is, therefore, antiatherogenic. BA are strong transcriptional inhibitors of their own synthesis through their receptors, particularly FXR. 40 Deficiency of FXR receptor led to a reduced atherosclerosis in Ldlr −/− mice. 41 The increase of Nr1h4 expression in female at 18 weeks concord with the higher Fmo3 (discussed above) and could explain the higher atherosclerotic risk. Thus, increased BA metabolism observed could have protective effects on atherosclerosis progression in male offspring. Methylation level of these 2 genes did not differ between groups. Perhaps, the inspection of other regions of promoters would have revealed differences.
In conclusion, we showed that maternal hypercholesterolemia led to more atherosclerosis in offspring. We report in the present study that at early age, ApoE −/− female offspring born to hypercholesterolemic mothers were more susceptible to develop aortic root atherosclerosis as compared with male born to hypercholesterolemic mothers. Early neutral lipid-stained lesions sizes in aortic root were also positively associated with TMAO levels and increased Fmo3 mRNA expression. Gallbladder BA content and key genes involved in reverse cholesterol transport were affected in ApoE −/− female born to hypercholesterolemic mothers, highlighting the reduced efficiency of these pathways while male offspring seems to be protected. The modifications of mRNA expression could be because of DNA methylation which may at least, in part, explain the perinatal hypercholesterolemia effect. In this study, we choose to not evaluate the role of sexual hormone because of the complexity of the protocol and the increasing animal manipulation. However, knowing the effect of estrogens on atherosclerosis development, 26, 42 the determination of these hormones levels in blood and using a more large number of animals may provide robust data to decrypt the role of sex.
Finally, our results are concordant with the recent proposed pathway linking TMAO and BA metabolism to atherosclerosis. 43 These finding emphasize the importance of perinatal cholesterol level and its programming effect during early life.
